New Drugs May Prolong Life For Patients With Pancreatic Cancer
The two new drugs are sunitib and everolimus. These two drugs have reportedly lengthened the survival time of advanced pancreatic cancer patients from 5 to 11 months.
The two new drugs are sunitib and everolimus. These two drugs have reportedly lengthened the survival time of advanced pancreatic cancer patients from 5 to 11 months.
In this case, a pancreatic cancer patient may die due to multiple organ failure once the cancer has spread and caused serious damage to the entire body.
Recently, experts claim to have discovered a way to cure pancreatic cancer during the early stages.